Echo Street Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $1.22 Million - $1.37 Million	4,257 New	4,257 $1.23 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $927,085 - $1.09 Million	-4,187 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $560,944 - $708,113	-3,169 Reduced 43.08%	4,187 $919,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $930,349 - $1.04 Million	5,129 Added 230.31%	7,356 $1.33 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $88,307 - $104,138	471 Added 26.82%	2,227 $449,000
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $171,205 - $199,563	827 Added 89.02%	1,756 $377,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $192,312 - $256,487	929 New	929 $220,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.